Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ripping The Bandage Off: GSK Resolves Suits On Many Products For $2.3 Bil.

Executive Summary

GlaxoSmithKline's decision to resolve its most onerous litigation in one fell swoop put it among the largest payouts by a pharma company

You may also be interested in...



GSK Ups Legal Reserve, May Break Pfizer's Settlement Record

GlaxoSmithkline expects to record a $3.4 billion legal charge relating to a government investigation of its marketing practices and Avandia product liability suits.

GSK’s $750 Mil. DoJ Settlement: When GMP Violations Equal Healthcare Fraud

GlaxoSmithKline’s $750 million settlement with the Department of Justice raises a worrisome question for industry: will violations of current good manufacturing practices become a target for whistleblower suits?

GSK’s $750 Mil. DoJ Settlement: When GMP Violations Equal Healthcare Fraud

GlaxoSmithKline’s $750 million settlement with the Department of Justice raises a worrisome question for industry: will violations of current good manufacturing practices become a target for whistleblower suits?

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS052441

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel